Herbalife (HLF) Cash & Equivalents (2009 - 2026)

Herbalife has reported Cash & Equivalents for 18 years, with the latest figure at $451.2 million in Q1 2026.

• Quarterly Cash & Equivalents rose 28.55% year-over-year to $451.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $451.2 million (up 28.55% YoY) and the FY2025 annual result came in at $353.1 million, down 19.4% from the prior year.
• Cash & Equivalents climbed to $451.2 million in Q1 2026 per HLF's latest filing, from $353.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $595.5 million in Q4 2023 and troughed at $305.5 million in Q3 2025.
• A 5-year average of $458.0 million and a median of $451.2 million in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents tumbled 30.3% in 2022, then grew 28.55% in 2026.
• Over 5 years, Cash & Equivalents stood at $516.3 million in 2022, then increased by 15.34% to $595.5 million in 2023, then retreated by 26.43% to $438.1 million in 2024, then decreased by 19.4% to $353.1 million in 2025, then rose by 27.78% to $451.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $451.2 million, $353.1 million, and $305.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.